Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy for invasive bladder cancer

S B Malkowicz1, D J Vaughn

  • 1Department of Surgery, University of Pennsylvania Medical Center, Philadelphia 19104, USA.

Urology
|April 1, 1996
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

A method to improve reconstruction of the distribution of hemoglobin, oxygenation, and MLu concentration in the human prostate before and after photodynamic therapy.

Proceedings of SPIE--the International Society for Optical Engineering·2015
Same author

A heterogeneous algorithm for PDT dose optimization for prostate.

Proceedings of SPIE--the International Society for Optical Engineering·2015
Same author

Steady state expression of cell-cycle regulatory genes in prostate carcinoma cell lines.

Urologic oncology·2011
Same author

Sleep and daily functioning during androgen deprivation therapy for prostate cancer.

European journal of cancer care·2010